Using Optical Genome Mapping and NGS to Understand Epitheliod Sarcoma in a Pediatric Patient
Protean BioDiagnostics to present on the use of optical genome mapping and NGS to understand epitheliod sarcoma in a pediatric patient.
Here we are presenting a unique approach to diagnose and treat pediatric epithelioid sarcoma, a rare and commonly misdiagnosed soft-tissue tumor.
Combining traditional next generation sequencing with optical genome mapping presents a robust picture of the precise genomic alterations. Evidence of these specific structural alterations combined with immunohistochemistry provides clinically relevant variants for genetic disease, which can be utilized to identify actionable targets for therapy, and more optimal outcome for the patient.
The abstract will be presented on Friday May 6th at ASPHO.
About Protean BioDiagnostics
Protean BioDiagnostics is revolutionizing modern healthcare with our Protean MAPS™ system, which integrates health screening, diagnostics, treatment guidance, and tele-medicine backed decision support.
We collaborate with physicians and health groups to support them in providing the best possible care for their patients, regardless of where they live.